Lamdong Pharmaceutical Share Price

Equities

LDP

VN000000LDP3

Pharmaceuticals

End-of-day quote HANOI S.E. 03:30:00 24/05/2024 am IST 5-day change 1st Jan Change
22,500 VND +3.69% Intraday chart for Lamdong Pharmaceutical -2.17% +41.51%
Dynamic Chart
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Lamdong Pharmaceutical Joint Stock Company announced that it expects to receive VND 907.5 billion in funding CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
APG Securities Joint Stock Company acquired additional 3.71% stake in Lamdong Pharmaceutical Joint Stock Company. CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Ladophar Herbal Beverage One Member Company Limited announced that it expects to receive VND 74 billion in funding from Lamdong Pharmaceutical Joint Stock Company CI
Ladophar Pharmaceutical Research & Application Co., Ltd announced that it expects to receive VND 40 billion in funding from Lamdong Pharmaceutical Joint Stock Company CI
More news
1 day+3.69%
1 week-2.17%
Current month-4.26%
1 month-1.32%
3 months+70.45%
6 months+50.00%
Current year+41.51%
More quotes
1 week
20 200.00
Extreme 20200
23 400.00
1 month
20 100.00
Extreme 20100
25 000.00
Current year
11 500.00
Extreme 11500
25 000.00
1 year
6 300.00
Extreme 6300
25 000.00
3 years
4 200.00
Extreme 4200
55 000.00
5 years
4 200.00
Extreme 4200
55 000.00
10 years
4 200.00
Extreme 4200
55 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 24/20/24
Director/Board Member 73 01/91/01
Members of the board TitleAgeSince
Director/Board Member 73 01/91/01
Chairman - -
Director/Board Member - 26/21/26
More insiders
Lamdong Pharmaceutical Joint Stock Company (Ladophar) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacturing and wholesale trading of pharmaceutical products, as well as functional food, alcoholic and non-alcoholic beverages, including tea and soft drinks. It also imports and exports materials for drug manufacturing activities, along with other medical equipment and supplies. In addition, the Company operates a hotel in Da Lat City, Lam Dong Province. The Company's revenue is derived from four segments: Dalat office and other provinces, drug store system in Lam Dong Province, Hochiminh City branch and Hanoi branch.
More about the company